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Risk–benefit analysis
An association between severe acne and an increased 
risk of attempted suicide has been documented, but a 
suspected relationship between severe acne treatment 
with isotretinoin and increased suicide has been difficult 
to confirm. Sundström and colleagues recently completed 
a retrospective cohort study of the standardized incidence 
ratio of suicide attempts in 5,756 patients who received iso­
tretinoin treatment for severe acne. Overall, a significantly 
increased risk of attempted suicide 6 months after treatment 
cessation was observed; however, the risk of attempted sui­
cide was already rising in these acne patients in the years 
before treatment initiation, confirming that in the absence of 
successful treatment, severe acne itself carries an increased 
risk of attempted suicide. These results indicate that treatment 
with isotretinoin may attenuate suicidal behavior, whereas 
for certain vulnerable patients this treatment may trigger 
such behavior. Therefore, determining patients’ vulnerability 
before prescribing treatment is a challenging area for future 
studies. (BMJ 341:c5812, 2010) Selected by H. Williams
Intraocular mutations
A common risk factor for uveal melanoma is nevus of Ota, 
a bluish­gray hyperpigmentation in the sclera and periorbital 
dermis. Previous studies identified mutations in the GTPase 
GNAQ in 83% of blue nevi but no mutations in the related 
GNA11. In addition, 46% of primary uveal melanoma lesions 
harbored mutations at the GNAQ mutational hotspot, Q209, 
which, if mutated, locks this multisubunit GTPase in a consti­
tutively active state. In a recent paper, Van Raamsdonk and 
colleagues sequenced exon 5 of GNAQ and the para logous 
GNA11 from 713 melanomas, including 183 uveal 
melanomas and 139 blue nevi. This analysis led to the iden­
tification of constitutively active mutations in either GNAQ 
or GNA11 in 83% of uveal melanomas. This finding suggests 
that activation of the Gαq–Gα11 pathway is the primary route 
for development of uveal melanoma. Furthermore, evidence 
from these studies as well as mouse tumor studies suggests 
that GNA11 mutations exert a more potent effect on melano­
cytes than do mutations in GNAQ. (N Engl J Med 363:2191–
9, 2010) Selected by P. Bergstresser
Combating resistance
Despite the recent development of small­molecule BRAF 
inhibitors for the treatment of melanoma, an aggressive skin 
cancer in which cells often harbor activating mutations in 
BRAF, chronic treatment with these drugs results in drug 
resistance, which is a common challenge associated with 
anticancer drugs. In a recent study of the molecular mecha­
nism of such acquired resistance, Villanueva and colleagues 
demonstrated that BRAF­mutant melanoma cells developed 
resistance to BRAF inhibitors via a switch among the BRAF, 
CRAF, and ARAF isoforms in order to activate the mitogen­
activated protein kinase pathway. Furthermore, the finding 
that chronic BRAF inhibition is associated with enhanced 
IGF­1R and phosphoinositide 3­kinase (PI3K)/AKT activity 
in melanoma cells that develop resistance to these inhibi­
tors offers a potential therapeutic approach of targeting 
both MEK and IGF­1R/PI3K to overcome the acquired resis­
tance to BRAF inhibitors. (Cancer Cell 18:683–95, 2010) 
Selected by M. Herlyn
In support of sunscreen
Although exposure to solar UVR is the only established 
modifiable cause of melanoma, the question of whether 
sunscreen use prevents melanoma is controversial even in 
the face of multiple case–control and cohort studies. Green 
and colleagues examined whether long­term application of 
sunscreen decreased cutaneous melanoma by analyzing the 
long­term follow­up data of a randomized sunscreen trial of 
1,621 adults in Queensland, Australia. Regular application 
of SPF 15+ sunscreen during the 5­year trial period reduced 
the incidence of new primary melanomas even 10 years after 
the end of the trial. These findings offer support for the use of 
sunscreen in adults to decrease the incidence of melanoma 
and suggest that long­term sunscreen intervention among 
children may offer even greater benefits in melanoma pre­
vention, because early­life sun exposure is thought to be crit­
ical for melanomagenesis. (J Clin Oncol 29:257–63, 2010) 
Selected by M. Weinstock
Diminished conversion
Bald scalp in adrogenetic alopecia (AGA) features minia­
turization of the hair follicle. To determine whether this 
decrease is caused by a lack of hair follicle stem or pro­
genitor cells, Garza and colleagues examined cells from the 
stem and progenitor compartments in bald and haired scalp 
from individuals with AGA for expression of cytokeratin 
15 (KRT15), CD200, CD34, and integrin α6 (ITGA6). The 
KRT15hiITGA6hi stem cells were preserved in bald scalp, 
whereas populations of CD200hiITGA6hi and CD34hi cells, 
which express a more activated phenotype and most likely 
arise from the detected stem cell population, were dimin­
ished. Examination of the analogous CD200hiITGA6hi pop­
ulation from mice revealed that these cells are multipotent 
and regenerate hair follicles in a skin reconstitution assay. 
Thus, these results suggest that AGA results from diminished 
conversion of hair follicle stem cells to progenitor cells as 
opposed to a distinct lack of hair follicle stem cells. (J Clin 
Invest 121:613–22, 2011) Selected by J. McGrath
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